In a partial victory for both sides, a federal judge in New York has certified a narrow class of "third-party payors," such as pension funds, labor unions and insurance companies, in their claim that Eli Lilly committed fraud by overpricing its anti-psychotic drug Zyprexa, while overstating its utility and understating its drawbacks. The judge also ordered the release of about 350 sealed documents that were obtained by a New York Times reporter in a controversial legal end-run.
Narrow Zyprexa Class Certified, Sealed Files Released
New York Law Journal
September 8, 2008